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INTRODUCTION:  The  intraductal  papillary  mucinous  neoplasms  (IPMNs)  are  increasingly  diagnosed  enti-
ties  with  high  potential  of malignancy  and signiﬁcant  recurrence  rates.
PRESENTATION OF  CASE:  In this  case  report  a rare  mixed  IPMN  with  full invasion  of the  pancreatic  ducts
was  identiﬁed.
DISCUSSION:  Difﬁculties  in  determining  the  grade  of pancreatic  duct  involvement  make  the  surgicaleywords:
ntraductal papillary mucinous neoplasms
IPMNs)
ultifocal
ancreatectomy
management  tough.
CONCLUSION: In multifocal  IPMNs  the  management  of  the  patients  is  even  more  challenging.  In this  case
the  patient  was  treated  successfully  with  total  pancreatectomy.
© 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. 
Open access under CC BY-NC-ND license.ntraductal
. Introduction
Intraductal papillary mucinous neoplasms (IPMNs) along with
he mucinous cystic neoplasms (MCNs) of the pancreas consist the
ast majority of the non inﬂammatory cystic entities detected in the
ancreatic gland. They are increasingly diagnosed the last decades
s non speciﬁc ﬁndings during the investigation scans for other
odalities.
The major histological difference between these two cystic
ucin producing neoplasms is the presence of an ovarian-type
troma in the MCNs whereas the most signiﬁcant clinical differ-
nces are the malignant potential along with the high recurrence
ates following resection which has been reported in patients with
PMNs. The majority of IPMNs (75%) are located in the head of the
ancreas and the rest are located in the body or the tail.1
Ofﬁcially IPMNs, are classiﬁed based on their location to – main
uct intraductal papillary mucinous neoplasms (MDIPMN) when
hey involve the duct of Wirsung – side duct intraductal papillary
ucinous neoplasms (SDIPMN) when they originate from the side
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ttp://dx.doi.org/10.1016/j.ijscr.2013.06.009branches and – mixed neoplasms when both type of branches are
involved.
It is widespread adopted that MDIPMNs possess a higher risk
of being malignant compared to the branch type. Moreover, it has
been highlighted that in many occasions the real grade of dysplasia
had been underestimated pre operatively. The current difﬁculties
in determining with accuracy all the dysplastic sites as well the
degree of dysplasia in the pancreatic system, despite the mod-
ern preoperative diagnostic techniques, has led to recurrences and
reoperations.2
The prognosis and the treatment of these tumors remain
object of dispute. The type of the resection should depend on the
pre-operative and the intra-operative ﬁndings.3 The presence of
positive intra-operative frozen resectional margins for carcinoma
in situ or invasive carcinoma can lead to the extension of the
resection.
In some cases the disease can be multifocal and rarely the entire
pancreas and the pancreatic ductal system can be involved; then
total pancreatectomy is the treatment of choice.4 Here, we present
a very rare case of a patient with an invasive IPMN which had occu-
pied the whole pancreatic gland and had involved the main and
almost all the branch ducts.
2. Case descriptionA  62-year old man  presented in November of 2012 with a 3
months history of abdominal fullness, pain and epigastric discom-
fort, especially after meals. The patient was  jaundiced with total
s Ltd. Open access under CC BY-NC-ND license.
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of the pancreatic ductal system, restricted pancreatectomies are
considered to be enough, with low recurrence rates (1.3–9.3%) and
preservation of big part of the pancreatic function.7 The docu-
mented recurrences in the pancreatic remnant have been managedig. 1. The MRA  showed no invasion of the SMA, whereas it was  indicative of the
ull  invasion of the pancreatic gland by the neoplasm.
ilirubin: 3.2 mg/dl and direct bilirubin 2.4 mg/dl. He was  diabetic
eceiving insulin for the last two years. His thyroid gland had multi-
le nodules; however, he was euthyroid without receiving therapy.
e also had an acute myocardial infarction 20 years before, treated
ith antiplatelet drugs and without further symptoms after-wards.
The ﬁrst imaging test carried out was abdominal ultrasono-
raphy (U/S) which showed diffuse heterogenity of the pancreas
nd computed tomography (CT) was recommended. In the CT scan
arked dilatation of the main pancreatic duct was  revealed along
ith diffuse deteriorations of the body and the tail of the pancreas.
he laboratory tests out of the normal values were the follow-
ng: ALP:555 IU/L AST:179 IU/L, ALT:368 IU/L, Amy: 362 IU/L,  GT:
15 IU/L. Among the tumor markers CEA and Ca 19-9 were out of
he normal range (10.8 g/L and 250.9 U/mL, respectively).
The second imaging test performed was endoscope ultrasono-
raphy (EUS) with ﬁne needle aspiration (FNA) of the lesions of
he head, body and tail (Fig. 1). The results of the FNA were indica-
ive for non invasive IPMN in the head of the pancreas, for invasive
PMN in the tail and probable for invasive carcinoma in the body
f pancreas. The differential diagnosis between carcinoma in situ
nd invasive IPMN was necessary. The immunohistochemical tests
ere positive for CDX2, MUC  5ac and for MUC1 and MUC2. The
i67 was greater than 70–80% in the head and especially in the tail
pecimens.
Magnetic resonance angiography (MRA) was also performed in
rder to exclude the inﬁltration of the vessels (Figs. 2 and 3).
The MRA  showed no vascular involvement and total pancrea-
ectomy, splenectomy and cholocystectomy were performed in an
pen procedure.
The histopathological examination revealed a pancreas of a total
ize of 11 cm × 6 cm × 3.5 cm.  The pancreatic tissue was  totally
ccupied by neoplasmatic tumor compatible with IPMN. The IPMN
as related with the main duct and almost with all of the branch
ucts. High grade epithelial dysplasia with development of invasive
arcinoma with an intermediate differentiation was also found. The
eoplasmatic cells were positive for CDX2 and less for MUC5AC and
UC2. The carcinoma was focally inﬁltrating the muscle layer of the
uodenum and presented perineural kind of inﬁltration. Three of
he 9 lymph nodes were inﬁltrated by metastatic carcinoma.
The postoperative course was uneventful and the patient was
ischarged 12 days after the operation.
. DiscussionMultifocal involvement of the branch ducts along with involve-
ent of the main pancreatic duct has been reported in the literature
ut the prevalence of this diffused type is still unknown.1Fig. 2. (a) The pancreatic duct was dilated in the preoperative EUS. (b) FNA/head of
the pancreas. One of the multiple FNA biopsies taken from the gland and the ductal
system which was  suggestive for non invasive IPMN in the head of the pancreas.
The major problem with the multiple locations is the inabil-
ity to obtain an accurate preoperative histological diagnosis and
staging for all the lesions. Imaging tests such as endoscopic retro-
grade cholangiopancreatography (ERCP), EUS, pancreatoscopy or
even intraductal U/S have been documented to be useful in order
to determine the necessity for a pancreatic resection without accu-
rate results for the type of the malignancy though.4–6 In cases of
non invasive IPMNs, and especially those localized in the branchesFig. 3. Neoplasmatic cells of the pancreas positive for CDX2.
 –  O
al of S
s
a
m
s
p
r
n
o
i
r
I
t
f
n
m
a
r
a
s
o
w
H
I
I
p
l
p
t
o
c
o
t
i
ﬁ
C
F
1
1CASE  REPORT
M.C. Makris et al. / International Journ
uccessfully with repeat resection. The presence of invasive cancer
t the frozen section of the surgical margins is the deﬁnite deter-
inant for the additional or even the total pancreatectomy. Several
tudies support that total resection of the pancreas should not be
erformed in cases of non invasive and localized IPMNs.8–10 The
ecurrence rates of invasive IPMNs is much higher compared to the
on invasive types (12–68%) with the majority of the recurrences
ccurring at distal sites such as the liver and lymph nodes and not
n the pancreatic remnant.7,11,12 Published studies report that the
ecurrence rates following partial and total resection in invasive
PMNs were similar showing no oncological advantage in favor of
he total pancreatectomies.11,12 Moreover the importance of the
ollow up of these patient has been discussed and supported by
umerous studies.
In multifocal IPMNs the management of the patients is even
ore challenging. Published studies highlight successful man-
gement of such cases with conservative management and with
egional or total pancreatectomy. In the study of Salvia et al.,
mong 131 patients with multifocal BD-IPMN, 121 patients were
uccessfully maggeded without surgery.8 Moreover in the case
f Chiang et al. a patient with a mixed type IPMN was  managed
ith an extended Whipple operation with distal pancreatectomy.4
owever, all these cases report non invasive types of carcinoma.
nvasive mixed IPMNs, are rarely documented in the literature.
In this case we presented a very aggressive type of diffused
PMN involving all the pancreatic duct system managed with total
ancreatectomy. Although, the results of the preoperative FNA fol-
owing the EUS showed non invasive IPMN in the head of the
ancreas, and invasive type in the body and the tail, the ﬁndings of
he histopathological examination post operatively were indicative
f pancreatic tissue totally inﬁltrated by an invasive tumor with the
haracteristics of an IPMN, which was moreover related to the total
f the pancreatic ductal system. Other highlights of this case were
he inﬁltration of the muscle layer of the duodenum along with 3
nﬁltrated lymph nodes. Based on our literature search, this is the
rst report, describing such an aggressive form of IPMN.
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